[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Alpine Immune Sciences, Inc. Common Stock (ALPN)
Alpine Immune Sciences (ALPN) sees significant social media buzz driven by insider transactions and positive clinical trial data for Povetacicept. Vertex Pharmaceuticals' potential acquisition is also a major point of discussion.
About Alpine Immune Sciences, Inc. Common Stock
Alpine Immune Sciences, Inc. is a healthcare company focused on immunology, trading under the ticker ALPN.
Alpine Immune Sciences, Inc. Common Stock uses the ticker $ALPN for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Alpine Immune Sciences, Inc. Common Stock (ALPN) social dominance is up XXX% from the previous X months.
- Alpine Immune Sciences, Inc. Common Stock (ALPN) creators is up XXX% from the previous week.
- Alpine Immune Sciences, Inc. Common Stock (ALPN) mentions is up XXX% from the previous week.
- Alpine Immune Sciences, Inc. Common Stock (ALPN) posts created is up 2100% from the previous week.
Price: $XX
Price 24-Hour Time-Series Raw Data
The stock price has reached a 1-year high, driven by positive clinical trial data for Povetacicept and insider transactions, indicating strong investor confidence. This is occurring despite ALPN's market dominance being near a 52-week low, suggesting that social sentiment and specific company news are currently outweighing broader market share metrics.
1-Year High: $XX on 2024-12-13
1-Year Low: $XX on 2024-12-13
AltRank: XXXXX
AltRank 24-Hour Time-Series Raw Data
Alpine Immune Sciences, Inc. Common Stock (ALPN) is currently AltRank #1,721 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXXXX +8
X Month: XXXXX +141
X Months: XXXXX +1,080
X Year: XXXXX +235
1-Year High: XXXXX on 2025-08-23
1-Year Low: XX on 2025-01-05
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +2
X Month: XX +3
X Months: XX +1
X Year: XX -XX
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2025-06-05
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXXXX -XXXX%
X Month: XXXXXX +40%
X Months: XXXXXX -XX%
X Year: XXXXXXX -XX%
1-Year High: XXXXXX on 2024-12-23
1-Year Low: XX on 2025-09-15
Engagements by network (24h): X: XXX
Mentions: X (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: XX +275%
X Month: XX +81%
X Months: XXX -XX%
X Year: XXXXX -XX%
1-Year High: XXX on 2025-01-23
1-Year Low: X on 2025-09-06
Mentions by network (24h): X: XX
Creators: X (24h)
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Alpine Immune Sciences, Inc. Common Stock (ALPN) in the last XX hours which is no change from in the previous XX hours
Daily Average: X
X Week: XX +375%
X Month: XX +200%
X Months: XXX -XX%
X Year: XXX -XX%
1-Year High: XX on 2025-01-23
1-Year Low: X on 2025-07-06
The most influential creators that mention Alpine Immune Sciences, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @insiderscreener | X | XXXXX | X | XXX |
Social Dominance: XXXXXXXXXXXXXXXXXXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXXXXXXXXXXXXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXXX% +0.00041%
X Month: XXXXXXX% +0.00037999999999999997%
X Months: XXXXXXX% -XXXXXXX%
X Year: XXXXXXX% -XXXXXXX%
1-Year High: XXXXX% on 2025-01-02
1-Year Low: XXXXXX% on 2025-09-20
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-04-08
1-Year Low: XXXXXXX% on 2025-12-11
Top Alpine Immune Sciences, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"3 Swiss companies have reported insider transactions today including Alpine Select AG $ALPN Galderma Group AG $GALD and Sunrise Communications AG"
X Link @insiderscreener 2025-12-09T18:10Z 3313 followers, XXX engagements
"$CRVS $600M MC Buyouts post Ph 1/2a POC (some open label) while $CRVS Cohort X data in Jan is PBO-controlled randomized w/ good safety - $DICE by $LLY $2.4B Ph X - $RXDX by $MRK $10.8B Ph 2a open label - $ALPN by $VRTX $4.9B Ph 1b/2a - $MORF by $LLY $3.2B Ph 2a open label"
X Link @HOThomasWPhelps 2025-11-14T08:48Z 1886 followers, 9769 engagements
"An approval for Povetacicept (formerly ALPN-303) would also be a success for German based #Evotec. They have a multi-year partnership with $ALPN which was acquired by $VRTX for $4.9B in 2024"
X Link @doepke_michel 2025-11-09T11:45Z 5926 followers, 3975 engagements
"3 Swiss companies have reported insider transactions today including Swatch Group AG $UHR Alpine Select AG $ALPN Jiangsu Eastern Shenghong Co. and Ltd"
X Link @insiderscreener 2025-02-26T17:15Z 3313 followers, 38.6K engagements